this study of 183 ambulatory patients with steroid-dependent asthma was conducted to evaluate the efficacy and safety of nebulized bitolterol mesylate solution ( 0.2 % ) compared to isoproterenol hydrochloride solution ( 0.3 % ) .
C0004096
asthma
C0106575
bitolterol mesylate